Clinical study on the efficacy and safety assessment of BlephEx treatment for blepharitis and meibomian gland dysfunction - Clinical study for blepharitis and meibomian gland dysfunction

Ishinkai Group Niimi Eye Istitute0 个研究点目标入组 20 人开始时间: 2018年4月2日最近更新: 2023年10月17日

适应症

试验速览

阶段: 不适用
状态: 尚未招募
发起方
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Improvement of meibomian gland infarction and improvement of eyelash and eyelash root contamination were observed by BlephEx treatment, but the feeling of dryness of eyes was not completely cured in the case of contact wearer. Moreover, it was found that cosmetic contaminations of eyelashes and eyelid margins with mascara and eyebrows are easier to remove with BlephEx treatment if washed out to some extent before BlephEx treatment.

研究设计

研究类型: Interventional

入排标准

年龄范围: > 18age old 至 ot applicable（—）
性别: All

入选标准

•Patients who are 18 years of age or older who are suspected of blepharitis or meibomian gland dysfunction

排除标准

•Patients with acute conjunctivitis, severe allergy, eyelid cleft wound, corneal structural vulnerability

研究者

发起方

Ishinkai Group Niimi Eye Istitute

相似试验

已完成

不适用

iLux Treatment for Meibomian Gland Dysfunction (MGD)Evaporative Dry Eye

NCT03055650Tear Film Innovations, Inc.30

已完成

不适用

iLux Treatment for Meibomian Gland DysfunctionEyes Dry ChronicMeibomian Gland Dysfunction

NCT06278584Clínica de Oftalmología de Cali S.A130

已完成

1 期

Topical Interferon Gamma for Macular Edema Secondary to UveitisAnterior UveitisUveitis

NCT01376362National Eye Institute (NEI)5

已完成

4 期

Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland DysfunctionDry Eye SyndromesMeibomian Gland Dysfunction

NCT03318874Oslo University Hospital70

终止

3 期

UNITE Study: Understanding New Interventions With GBM ThErapyGlioblastoma Multiforme

NCT03419403AbbVie40